Oligonucleotide Pool Market By Types, Applications and End Users - Global Industry Analysis & Forecast to 2027
Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101533
Oligonucleotide Pool Market By Types (DNA pool and RNA pool), Applications (Diagnostics & Therapeutics and Research) End Users (Pure Academic Research, Commercial Research And Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Oligonucleotide pool Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Oligonucleotides are short DNA or RNA particles, oligomers, which have an extensive variety of utilizations in research, genetic testing, and forensics. Usually composed in the lab by solid-phase chemical synthesis, these little bits of nucleic acids can be fabricated as single-stranded particles with any client indicated grouping, as are crucial for synthesis of artificial gene, DNA sequencing, polymerase chain reaction (PCR), library development and as atomic tests. In nature, oligonucleotides are typically -present as little RNA atoms that capacity in the direction of quality articulation (e.g. microRNA), or are corruption intermediates got from the breakdown of bigger nucleic acid atoms.
Market Segmentation
Based on type the DNA pool has the biggest share of the market of oligonucleotide pool and is anticipated to be constant in future. On the basis of application the Research segment leads the market and is foreseen op grow significantly over the forecast period. By end user the commercial research segment holds the largest market share.
Regional Insights
Geographically, the development of the market has boosted significantly in the Asia Pacific region. Besides, North America dominated the market owing to existence of large number of small scale and big scale manufacturers.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Integrated DNA Technologies
- MYcroarray
- Sigma-Aldrich
- Creative Biogene
- Twist Bioscience
- CustomArray, Inc.
- TriLink BioTechnologies, Inc.
- Agilent Technologies
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Oligonucleotide pool Market, By Type, Estimates and Forecast, 2017-2027($Billion)
o DNA pool
o RNA pool
· Oligonucleotide pool Market, By Application, Estimates and Forecast, 2017-2027($Billion)
o Diagnostics & Therapeutics
o Research
· Oligonucleotide pool Market, By End User, Estimates and Forecast, 2017-2027($Billion)
o Commercial Research
o Pure Academic Research
o Others
· Oligonucleotide pool Market, By Region, Estimates and Forecast, 2017-2027($Billion)
o North America
§ North America Oligonucleotide pool Market, By Country
o U.S. Oligonucleotide pool Market
o Canada Oligonucleotide pool Market
o Mexico Oligonucleotide pool Market
o Europe
§ Europe Oligonucleotide pool Market, By Country
o Germany Oligonucleotide pool Market
o UK Oligonucleotide pool Market
o France Oligonucleotide pool Market
o Russia Oligonucleotide pool Market
o Italy Oligonucleotide pool Market
o Rest of Europe Oligonucleotide pool Market
o Asia-Pacific
§ Asia-Pacific Oligonucleotide pool Market, By Country
o China Oligonucleotide pool Market
o Japan Oligonucleotide pool Market
o South Korea Oligonucleotide pool Market
o India Oligonucleotide pool Market
o Southeast Asia Oligonucleotide pool Market
o Rest of Asia-Pacific Oligonucleotide pool Market
o South America
§ South America Oligonucleotide pool Market
o Brazil Oligonucleotide pool Market
o Argentina Oligonucleotide pool Market
o Columbia Oligonucleotide pool Market
o Rest of South America Oligonucleotide pool Market
o Middle East and Africa
§ Middle East and Africa Oligonucleotide pool Market
o Saudi Arabia Oligonucleotide pool Market
o UAE Oligonucleotide pool Market
o Egypt Oligonucleotide pool Market
o Nigeria Oligonucleotide pool Market
o South Africa Oligonucleotide pool Market
o Rest of MEA Oligonucleotide pool Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Oligonucleotide Pool Market, By Type
5.1. Introduction
5.2. Global Oligonucleotide Pool Revenue and Market Share by Type (2017-2027)
5.2.1. Global Oligonucleotide Pool Revenue and Revenue Share by Type (2017-2027)
5.3. DNA pool
5.3.1. Global DNA pool Revenue and Growth Rate (2017-2027)
6. Oligonucleotide Pool Market, By Application
6.1. Introduction
6.2. Global Oligonucleotide Pool Revenue and Market Share by Application (2017-2027)
6.2.1. Global Oligonucleotide Pool Revenue and Revenue Share by Application (2017-2027)
6.3. Diagnostics and therapeutics
6.3.1. Global Diagnostics and therapeutics Revenue and Growth Rate (2017-2027)
6.4. Research
6.4.1. Global Research Revenue and Growth Rate (2017-2027)
7. Oligonucleotide Pool Market, By End User
7.1. Introduction
7.2. Global Oligonucleotide Pool Revenue and Market Share by End User (2017-2027)
7.2.1. Global Oligonucleotide Pool Revenue and Revenue Share by End User (2017-2027)
7.3. Pure Academic Research
7.3.1. Global Pure Academic Research Revenue and Growth Rate (2017-2027)
7.4. Commercial Research
7.4.1. Global Commercial Research Revenue and Growth Rate (2017-2027)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2027)
8. Oligonucleotide Pool Market, By Region
8.1. Introduction
8.2. Global Oligonucleotide Pool Revenue and Market Share by Regions
8.2.1. Global Oligonucleotide Pool Revenue by Regions (2017-2027)
8.3. North America Oligonucleotide Pool by Countries
8.3.1. North America Oligonucleotide Pool Revenue and Growth Rate (2017-2027)
8.3.2. North America Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Oligonucleotide Pool by Countries
8.4.1. Europe Oligonucleotide Pool Revenue and Growth Rate (2017-2027)
8.4.2. Europe Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Oligonucleotide Pool by Countries
8.5.1. Asia-Pacific Oligonucleotide Pool Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Oligonucleotide Pool by Countries
8.6.1. South America Oligonucleotide Pool Revenue and Growth Rate (2017-2027)
8.6.2. South America Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Oligonucleotide Pool by Countries
8.7.1. Middle East and Africa Oligonucleotide Pool Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Integrated DNA Technologies
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. MYcroarray
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Sigma-Aldrich
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Creative Biogene
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Twist Bioscience
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. CustomArray, Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. TriLink BioTechnologies, Inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Agilent Technologies
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
10. Global Oligonucleotide Pool Market Competition, by Manufacturer
10.1. Global Oligonucleotide Pool Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Oligonucleotide Pool Price By Region (2017-2017)
10.3. Top 5 Oligonucleotide Pool Manufacturer Market Share
10.4. Market Competition Trend
11. Oligonucleotide Pool Market Forecast (2017-2027)
11.1. Global Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Oligonucleotide Pool Market Forecast by Regions (2017-2027)
11.2.1. North America Oligonucleotide Pool Market Forecast (2017-2027)
11.2.1.1. United States Oligonucleotide Pool Market Forecast (2017-2027)
11.2.1.2. Canada Oligonucleotide Pool Market Forecast (2017-2027)
11.2.1.3. Mexico Oligonucleotide Pool Market Forecast (2017-2027)
11.2.2. Europe Oligonucleotide Pool Market Forecast (2017-2027)
11.2.2.1. Germany Oligonucleotide Pool Market Forecast (2017-2027)
11.2.2.2. France Oligonucleotide Pool Market Forecast (2017-2027)
11.2.2.3. UK Oligonucleotide Pool Market Forecast (2017-2027)
11.2.2.4. Russia Oligonucleotide Pool Market Forecast (2017-2027)
11.2.2.5. Italy Oligonucleotide Pool Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Oligonucleotide Pool Market Forecast (2017-2027)
11.2.3. Asia-Pacific Oligonucleotide Pool Market Forecast (2017-2027)
11.2.3.1. China Oligonucleotide Pool Market Forecast (2017-2027)
11.2.3.2. Japan Oligonucleotide Pool Market Forecast (2017-2027)
11.2.3.3. Korea Oligonucleotide Pool Market Forecast (2017-2027)
11.2.3.4. India Oligonucleotide Pool Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Oligonucleotide Pool Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Oligonucleotide Pool Market Forecast (2017-2027)
11.2.4. South America Oligonucleotide Pool Market Forecast (2017-2027)
11.2.4.1. Brazil Oligonucleotide Pool Market Forecast (2017-2027)
11.2.4.2. Argentina Oligonucleotide Pool Market Forecast (2017-2027)
11.2.4.3. Columbia Oligonucleotide Pool Market Forecast (2017-2027)
11.2.4.4. Rest of South America Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5. Middle East and Africa Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5.3. Egypt Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5.4. Nigeria Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5.5. South Africa Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5.6. Turkey Oligonucleotide Pool Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Oligonucleotide Pool Market Forecast (2017-2027)
11.3. Oligonucleotide Pool Market Forecast by Type (2017-2027)
11.3.1. Oligonucleotide Pool Forecast by Type (2017-2027)
11.3.2. Oligonucleotide Pool Market Share Forecast by Type (2017-2027)
11.4. Oligonucleotide Pool Market Forecast by Application (2017-2027)
11.4.1. Oligonucleotide Pool Forecast by Application (2017-2027)
11.4.2. Oligonucleotide Pool Market Share Forecast by Application (2017-2027)
11.5. Oligonucleotide Pool Market Forecast by End User (2017-2027)
11.5.1. Oligonucleotide Pool Forecast by End User (2017-2027)
11.5.2. Oligonucleotide Pool Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Oligonucleotide Pool Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Oligonucleotide Pool Revenue and Revenue Share by Type (2017-2018)
Figure Global DNA pool Revenue and Growth Rate (2017-2018)
Table Global Oligonucleotide Pool Revenue and Revenue Share by Application (2017-2018)
Figure Global Diagnostics and therapeutics Revenue and Growth Rate (2017-2018)
Figure Global Research Revenue and Growth Rate (2017-2018)
Table Global Oligonucleotide Pool Revenue and Revenue Share by End User (2017-2018)
Figure Global Pure Academic Research Revenue and Growth Rate (2017-2018)
Figure Global Commercial Research Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Oligonucleotide Pool Revenue by Regions (2017-2018)
Figure North America Oligonucleotide Pool Growth Rate (2017-2018)
Figure North America Oligonucleotide Pool Revenue and Growth Rate (2017-2018)
Figure North America Oligonucleotide Pool by Countries (2017-2018)
Figure North America Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2018)
Figure United States Oligonucleotide Pool Growth Rate (2017-2018)
Figure United States Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Oligonucleotide Pool Growth Rate (2017-2018)
Figure Canada Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Oligonucleotide Pool Growth Rate (2017-2018)
Figure Mexico Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Oligonucleotide Pool Growth Rate (2017-2018)
Figure Europe Oligonucleotide Pool Revenue and Growth Rate (2017-2018)
Figure Europe Oligonucleotide Pool by Countries (2017-2018)
Figure Europe Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2018)
Figure Germany Oligonucleotide Pool Growth Rate (2017-2018)
Figure Germany Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Oligonucleotide Pool Growth Rate (2017-2018)
Figure France Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Oligonucleotide Pool Growth Rate (2017-2018)
Figure UK Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Oligonucleotide Pool Growth Rate (2017-2018)
Figure Russia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Oligonucleotide Pool Growth Rate (2017-2018)
Figure Italy Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Oligonucleotide Pool Growth Rate (2017-2018)
Figure Rest of Europe Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Oligonucleotide Pool Growth Rate (2017-2018)
Figure Asia-Pacific Oligonucleotide Pool Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Oligonucleotide Pool by Countries (2017-2018)
Figure Asia-Pacific Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2018)
Figure China Oligonucleotide Pool Growth Rate (2017-2018)
Figure China Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Oligonucleotide Pool Growth Rate (2017-2018)
Figure Japan Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Oligonucleotide Pool Growth Rate (2017-2018)
Figure Korea Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Oligonucleotide Pool Growth Rate (2017-2018)
Figure India Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Oligonucleotide Pool Growth Rate (2017-2018)
Figure Southeast Asia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Oligonucleotide Pool Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Oligonucleotide Pool Growth Rate (2017-2018)
Figure South America Oligonucleotide Pool Revenue and Growth Rate (2017-2018)
Figure South America Oligonucleotide Pool by Countries (2017-2018)
Figure South America Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Oligonucleotide Pool Growth Rate (2017-2018)
Figure Brazil Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Oligonucleotide Pool Growth Rate (2017-2018)
Figure Argentina Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Oligonucleotide Pool Growth Rate (2017-2018)
Figure Columbia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Oligonucleotide Pool Growth Rate (2017-2018)
Figure Rest of South America Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Oligonucleotide Pool Growth Rate (2017-2018)
Figure Middle East and Africa Oligonucleotide Pool Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Oligonucleotide Pool by Countries (2017-2018)
Figure Middle East and Africa Oligonucleotide Pool Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Oligonucleotide Pool Growth Rate (2017-2018)
Figure Saudi Arabia Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Oligonucleotide Pool Growth Rate (2017-2018)
Figure United Arab Emirates Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Oligonucleotide Pool Growth Rate (2017-2018)
Figure Egypt Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Oligonucleotide Pool Growth Rate (2017-2018)
Figure Nigeria Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Oligonucleotide Pool Growth Rate (2017-2018)
Figure South Africa Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Oligonucleotide Pool Growth Rate (2017-2018)
Figure Turkey Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Oligonucleotide Pool Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2017-2018)
Table Integrated DNA Technologies Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Table MYcroarray Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sigma-Aldrich Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Creative Biogene Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Twist Bioscience Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CustomArray, Inc. Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Table TriLink BioTechnologies, Inc. Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Agilent Technologies Oligonucleotide Pool Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Oligonucleotide Pool Market Share by Manufacturer
Figure Global Oligonucleotide Pool Revenue and Market Share by Manufacturer
Table Global Oligonucleotide Pool Price by Region (2017-2017)
Figure Top 5 Oligonucleotide Pool Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Oligonucleotide Pool Revenue (Millions USD) and Growth Rate (2018-2025)
Table Oligonucleotide Pool Market Forecast by Regions (2018-2025)
Figure North America Oligonucleotide Pool Market Forecast (2018-2025)
Figure United States Oligonucleotide Pool Market Forecast (2018-2025)
Figure Canada Oligonucleotide Pool Market Forecast (2018-2025)
Figure Mexico Oligonucleotide Pool Market Forecast (2018-2025)
Figure Europe Oligonucleotide Pool Market Forecast (2018-2025)
Figure Germany Oligonucleotide Pool Market Forecast (2018-2025)
Figure France Oligonucleotide Pool Market Forecast (2018-2025)
Figure UK Oligonucleotide Pool Market Forecast (2018-2025)
Figure Russia Oligonucleotide Pool Market Forecast (2018-2025)
Figure Italy Oligonucleotide Pool Market Forecast (2018-2025)
Figure Rest of Europe Oligonucleotide Pool Market Forecast (2018-2025)
Figure Asia-Pacific Oligonucleotide Pool Market Forecast (2018-2025)
Figure China Oligonucleotide Pool Market Forecast (2018-2025)
Figure Japan Oligonucleotide Pool Market Forecast (2018-2025)
Figure Korea Oligonucleotide Pool Market Forecast (2018-2025)
Figure India Oligonucleotide Pool Market Forecast (2018-2025)
Figure Southeast Asia Oligonucleotide Pool Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Oligonucleotide Pool Market Forecast (2018-2025)
Figure South America Oligonucleotide Pool Market Forecast (2018-2025)
Figure Brazil Oligonucleotide Pool Market Forecast (2018-2025)
Figure Argentina Oligonucleotide Pool Market Forecast (2018-2025)
Figure Columbia Oligonucleotide Pool Market Forecast (2018-2025)
Figure Rest of South America Oligonucleotide Pool Market Forecast (2018-2025)
Figure Middle East and Africa Oligonucleotide Pool Market Forecast (2018-2025)
Figure Saudi Arabia Oligonucleotide Pool Market Forecast (2018-2025)
Figure United Arab Emirates Oligonucleotide Pool Market Forecast (2018-2025)
Figure Egypt Oligonucleotide Pool Market Forecast (2018-2025)
Figure Nigeria Oligonucleotide Pool Market Forecast (2018-2025)
Figure South Africa Oligonucleotide Pool Market Forecast (2018-2025)
Figure Turkey Oligonucleotide Pool Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Oligonucleotide Pool Market Forecast (2018-2025)
Figure Global Oligonucleotide Pool Forecast by Type (2018-2025)
Figure Global Oligonucleotide Pool Market Share Forecast by Type (2018-2025)
Figure Global Oligonucleotide Pool Forecast by Type (2018-2025)
Figure Global Oligonucleotide Pool Forecast by Application (2018-2025)
Figure Global Oligonucleotide Pool Market Share Forecast by Application (2018-2025)
Figure Global Oligonucleotide Pool Forecast by Application (2018-2025)
Figure Global Oligonucleotide Pool Forecast by End User (2018-2025)
Figure Global Oligonucleotide Pool Market Share Forecast by End User (2018-2025)
Figure Global Oligonucleotide Pool Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|